← Eichor
Study identifier: NCT06360965 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain

Condition: Pelvic Inflammatory Disease · Chronic Pelvic Pain Syndrome  ·  Sponsor: Beijing Hospital of Integrated Traditional Chinese and Western Medicine

PhaseNA
Planned participants102
Who can joinFemale, 18 Years to 50 Years
Healthy volunteersNo

About this study

Chronic Pelvic Pain is one of the common gynecological symptoms, characterized by persistent and non periodic pain in the pelvic cavity and surrounding tissues. It is often seen as a sequelae of pelvic inflammatory diseases caused by the failure to receive timely and correct treatment. This study compares the effectiveness of warm meridians and relieve pain plaster in relieving the sequelae of pelvic inflammatory disease and chronic pelvic pain symptoms, and evaluates the safety of improved patches and traditional patches, further promoting it to community grassroots hospitals.

This description comes directly from the study's public registry record.

Talk to the study team

Yu Cao, Master  ·  13811911690  ·  howgreenbreeze@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing Hospital of Integrated Traditional Chinese and Western MedicineBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06360965